UBX | Unity Biotechnology, Inc. Stock Overview

(Stock Exchange: NASDAQ)

Day's Range	1.4100 - 1.4600
52 Week Range	1.2200 - 2.6000
Beta	1.08
Implied Volatility	67.49%
IV Rank	62.33%
Day's Volume	23,465
Average Volume	47,143
Shares Outstanding	16,847,600
Market Cap	23,755,116
Sector	Healthcare
Industry	Biotechnology
IPO Date	2018-05-03

Valuation
Profitability
Growth
Health
P/E Ratio	-0.73
Forward P/E Ratio	N/A
EPS	-1.92
1YR Price Target	N/A
Dividend Yield	N/A
Dividend Per Share	N/A
Dividend ExDate	N/A
Dividend PayDate	N/A
Employees	19
Country	USA
Website	UBX

Unity Biotechnology, Inc., a biotechnology company, engages in the research and development of therapeutics to slow, halt, or reverse diseases of aging. The company's lead drug candidate includes UBX1325, which is Phase II clinical trial for the treatment of age-related diseases of the eye, including diabetic macular edema, age-related macular degeneration, and diabetic retinopathy. It also develops UBX1967 for the treatment of ophthalmologic diseases; UBX2050, a human anti-Tie2 agonist monoclonal antibody for the treatment of age-related eye diseases; and UBX2089, a a-Klotho hormone drug candidate for multiple neurology indications. The company was formerly known as Forge, Inc. and changed its name to Unity Biotechnology, Inc. in January 2015. Unity Biotechnology, Inc. was incorporated in 2009 and is headquartered in South San Francisco, California.

UBX's peers: EXAI, IPA, MYMD, RXRX, AVIR, ICVX, HOOK, ABOS, HRTX, FIXX, RNA, BEAM, NTLA, EDIT, VERV, PRME, WINT, DRMA, ENSC, PBLA, BXRX, NLTX, NUVB, OVID, NXTC, CNTB, IVVD

*Chart delayed

Analyzing fundamentals for UBX we got that it has weak fundamentals where Valuation is considered to be significantly overvalued, Profitability is unacceptably poor, Growth is on medium level and Health is very weak. For more detailed analysis please see UBX Fundamentals page.

Watching at UBX technicals we can see that long-term trend is bearish, the same as bearish middle-term trend, as well as bearish short-term trend. More technicals details can be found on UBX Technicals page.